Black Diamond Therapeutics Inc – Cashflow (NASDAQ:BDTX) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit -52.15 M-100.15 M-85.08 M-66.72 M-62.3 M29.61 M 29.61 M Mittelzufluss aus Investitionstätigkeit -281.69 M130.61 M53.37 M16.35 M16.97 M-44.91 M -44.91 M Zahlungsströme aus der Finanzierungstätigkeit 214.94 M729 K177 K71.93 M25.55 M-146 K -146 K Freier Cashflow -52.29 M-102.86 M-85.27 M-66.75 M-62.3 M29.61 M 29.61 M

Nachrichten

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Black Diamond Therapeutics: Stifel bekräftigt "Buy"-Rating nach vielversprechenden Studiendaten

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Black Diamond Therapeutic (NASDAQ:BDTX), EastGroup Properties (NYSE:EGP)